Publication | Open Access

Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK

Swiss GroupOncologyGastrointestinal OncologyMedicinePathologyColorectal CancerMetastatic Colorectal CancerFirst-line TreatmentMolecular OncologyCancer TreatmentPharmacologyRadiation OncologyCancer Research